A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Type of Cancer
Leukemia

Site
Bethesda

Protocol Number
AV001

To Learn More Call
201-510-0910